Mainz Biomed Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio16.2826.37194.20216.13
P/B Ratio2.417.277.3019.62
Price/Tangible Book4.807.3019.62
Enterprise Value Ratios
EV/Revenue24.4427.30149.81215.66
Profitability & Returns
Return on Equity (ROE)-4.66%-3.03%-2.58%-6.46%
Return on Assets (ROA)-0.80%-0.93%-1.09%-1.13%
Return on Capital Employed (ROCE)-2.53%-4.32%-1.65%-1.12%23.49%
Leverage & Solvency Ratios
Debt/Equity0.542.280.230.41-1.09
Liquidity Ratios
Current Ratio1.320.974.337.110.27
Quick Ratio1.080.804.106.540.24
Efficiency Ratios
Asset Turnover0.060.050.040.11
Inventory Turnover0.650.98
Yield & Distribution Ratios
Earnings Yield-1.49%-1.11%-0.26%-0.09%
FCF Yield-1.18%-0.98%-0.15%-0.03%
Buyback Yield-1.38%-0.15%-0.96%-0.29%